EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Medarova, Z.
Right arrow Articles by Taylor, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Medarova, Z.
Right arrow Articles by Taylor, R. L., Jr.
Experimental Biology and Medicine 227:158-163 (2002)
© 2002 Society for Experimental Biology and Medicine


ORIGINAL ARTICLE

Alloantigen System L Affects the Outcome of Rous Sarcomas1

Zdravka Medarova*, W. Elwood Briles{dagger} and Robert L. Taylor, Jr.*,2

* Department of Animal and Nutritional Sciences, University of New Hampshire, Durham, New Hampshire 03824; and
{dagger} Department of Biological Sciences, Northern Illinois University, DeKalb, Illinois 60115

This study was designed to examine the alloantigen system L effects on Rous sarcomas in three B complex genotypes. The parental stock was 50% Modified Wisconsin Line 3 x White Leghorn Line NIU 4 and 50% inbred Line 6.15-5. Pedigree matings of two B2B5 L1L2 sires to five B2B5 L1L2 dams per sire produced experimental chicks segregating for B and L genotypes. Chicks were inoculated with 20 pock-forming units (pfu) of Rous sarcoma virus (RSV) at 6 weeks of age. Tumors were scored six times over 10 weeks postinoculation after which the tumor scores were used to assign a tumor profile index (TPI) to each chicken. Tumor growth over time and TPI were evaluated by repeated-measures analysis of variance and analysis of variance, respectively. Six trials were conducted with a total of 151 chickens. The major histocompatibility (B) complex affected the responses as the B2B2 and B2B5 genotypes had significantly lower tumor growth over time and TPI than the B5B5 genotype. Separate analyses revealed no significant L system effect in B2B2 or B2B5 backgrounds. However, L genotype significantly affected (P < 0.05) both tumor growth over time and TPI in B5B5 chickens. B5B5 L1L2 birds had TPI significantly lower than B5B5 L1L1 chickens but not B5B5 L2L2. Mortality was lower in the B5B5 L1L2 birds than in B5B5 L2L2 chickens. The L system, or one closely linked, affects the growth and ultimate outcome of Rous sarcomas. The response may depend upon the genetic background as well as MHC type.

Key Words: erythrocyte alloantigen • major histocompatibility (B) complex • oncogene • Rous sarcoma virus • tumor







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Experimental Biology and Medicine.